Takeda Pharmaceutical Statistics
Total Valuation
TAK has a market cap or net worth of $41.98 billion. The enterprise value is $75.18 billion.
| Market Cap | 41.98B |
| Enterprise Value | 75.18B |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | Mar 27, 2024 |
Share Statistics
TAK has 3.14 billion shares outstanding. The number of shares has increased by 1.20% in one year.
| Shares Outstanding | 3.14B |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.67% |
| Float | 1.55B |
Valuation Ratios
The trailing PE ratio is 37.11 and the forward PE ratio is 23.04. TAK's PEG ratio is 3.23.
| PE Ratio | 37.11 |
| Forward PE | 23.04 |
| PS Ratio | 1.43 |
| Forward PS | 0.01 |
| PB Ratio | 0.96 |
| P/FCF Ratio | 8.53 |
| PEG Ratio | 3.23 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.79, with an EV/FCF ratio of 15.28.
| EV / Earnings | 59.79 |
| EV / Sales | 2.56 |
| EV / EBITDA | 10.79 |
| EV / EBIT | 30.94 |
| EV / FCF | 15.28 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.06 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 5.06 |
| Debt / FCF | 7.16 |
| Interest Coverage | 1.65 |
Financial Efficiency
Return on equity (ROE) is 2.60% and return on invested capital (ROIC) is 3.08%.
| Return on Equity (ROE) | 2.60% |
| Return on Assets (ROA) | 1.20% |
| Return on Capital (ROIC) | 3.08% |
| Revenue Per Employee | $598,858 |
| Profits Per Employee | $25,612 |
| Employee Count | 49,095 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | -194.49M |
| Effective Tax Rate | -18.30% |
Stock Price Statistics
The stock price has decreased by -20.64% in the last 52 weeks. The beta is 0.54, so TAK's price volatility has been lower than the market average.
| Beta (1Y) | 0.54 |
| 52-Week Price Change | -20.64% |
| 50-Day Moving Average | 14.14 |
| 200-Day Moving Average | 14.61 |
| Relative Strength Index (RSI) | 38.81 |
| Average Volume (30 Days) | 1,836,353 |
Short Selling Information
| Short Interest | 8.12M |
| Short Previous Month | 6.26M |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.52% |
| Short Ratio (days to cover) | 5.26 |
Income Statement
In the last 12 months, TAK had revenue of $29.40 billion and earned $1.26 billion in profits. Earnings per share was $0.36.
| Revenue | 29.40B |
| Gross Profit | 18.19B |
| Operating Income | 2.02B |
| Pretax Income | 957.67M |
| Net Income | 1.26B |
| EBITDA | 6.97B |
| EBIT | 2.43B |
| Earnings Per Share (EPS) | $0.36 |
Balance Sheet
The company has $2.05 billion in cash and $35.24 billion in debt, giving a net cash position of -$33.19 billion or -$10.58 per share.
| Cash & Cash Equivalents | 2.05B |
| Total Debt | 35.24B |
| Net Cash | -33.19B |
| Net Cash Per Share | -$10.58 |
| Equity / Book Value | 43.56B |
| Book Value Per Share | 13.88 |
| Working Capital | 947.69M |
Cash Flow
In the last 12 months, operating cash flow was $5.94 billion and capital expenditures -$1.02 billion, giving a free cash flow of $4.92 billion.
| Operating Cash Flow | 5.94B |
| Capital Expenditures | -1.02B |
| Free Cash Flow | 4.92B |
| FCF Per Share | $1.57 |
Margins
Gross margin is 61.87%, with operating and profit margins of 6.87% and 4.28%.
| Gross Margin | 61.87% |
| Operating Margin | 6.87% |
| Pretax Margin | 3.26% |
| Profit Margin | 4.28% |
| EBITDA Margin | 23.71% |
| EBIT Margin | 8.27% |
| FCF Margin | 16.74% |
Dividends & Yields
This stock pays an annual dividend of $0.62, which amounts to a dividend yield of 4.63%.
| Dividend Per Share | $0.62 |
| Dividend Yield | 4.63% |
| Dividend Growth (YoY) | 1.38% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 170.58% |
| Buyback Yield | -1.20% |
| Shareholder Yield | 3.44% |
| Earnings Yield | 3.00% |
| FCF Yield | 11.72% |
Analyst Forecast
The average price target for TAK is $20.00, which is 49.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.00 |
| Price Target Difference | 49.48% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TAK has an Altman Z-Score of 1.08 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.08 |
| Piotroski F-Score | 6 |